Učitavanje...

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018

Omadacycline is a broad-spectrum aminomethylcycline approved in October 2018 by the U.S. Food and Drug Administration for treating acute bacterial skin and skin structure infections and community-acquired pneumonia as both an oral and intravenous once-daily formulation. In this report, the activitie...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antimicrob Agents Chemother
Glavni autori: Pfaller, Michael A., Huband, Michael D., Shortridge, Dee, Flamm, Robert K.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7179604/
https://ncbi.nlm.nih.gov/pubmed/32071045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02488-19
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!